期刊文献+

重组人淋巴毒素随机点突变组合文库的构建 被引量:3

Construction of Combined Site-directed Random Mutation Libraries of Recombinant Human Lymphotoxin
在线阅读 下载PDF
导出
摘要 构建重组人淋巴毒素 (rhLT)随机点突变组合文库以进行体外分子进化及结构和功能的研究。应用含随机核苷酸序列的引物 ,通过OverlapPCR的方法分别对rhLT的 4 6、10 6和 130位氨基酸进行定点随机突变 ,获得各单点随机突变体库。通过基因操作将这三个单点随机突变体库拼接并克隆于pMD_18T载体建立三点组合突变体文库 ,DNA测序鉴定突变位点的随机性和多样性 ,原核表达该变异体库 ,体外测定生物学活性。成功获得rhLT三点随机点突变组合文库 ,其转化克隆数达到 1 5× 10 5,是多样性理论值的 4 5倍。 5 0个样品的序列分析显示各个位点的核苷酸和氨基酸序列的突变都呈随机性分布。对原核表达的 30个样品进行生物学活性测定 ,结果 70 % (2 1个 )的样品无活性、2 3 3% (7个 )的样品活性低于rhLT、6 7% (2个 )的样品活性高于rhLT。成功构建了rhLT随机点突变组合文库 ,该库不仅在一级结构上具有良好的随机性和多样性 ,而且具有生物学活性的多样性 ,为应用噬菌体展示等高通量筛选策略对淋巴毒素进行体外分子进化和结构与功能的深入研究打下了基础。 To construct the combined site_directed random mutation library of recombinant human Lymphotoxin (rhLT) for in vitro molecular evolution study, and to study the structure and function relationship. The random point mutations at the sites of 46,106 and 130 were individually generated by overlap PCR amplification with the random nucleotide primers. The three point mutations were combined and cloned into pMD_18T vector to construct the combined mutation library. DNA sequencing was used to evaluate the diversity and randomness of the mutation sites. The combined mutation library was re_engineered, inserted in prokaryotic expression vector pBV220, transformed and expressed in Escherichia coli strain DH5α.The biological activity of some of the mutants was tested in L929 mouse fibroblast cells. As much as 1.5×10 5 clones were obtained, which represents 4.5 times of the complete mutation libraries at 99% confidence. Sequencing 50 clones revealed no obvious bias in the nucleotide and amino acid mutations at the sites. Among the 30 expressed samples underwent for the bioassay, 70% (21 samples) were inactive, 23.3% (7 samples) had lower activity than rhLT, the remaining 6.7% (2 samples) had higher activity than rhLT. The combined site_directed random mutation library of rhLT has been constructed successfully. In combination with phase display, the library is ready for in vitro molecular evolution study.
出处 《生物工程学报》 CAS CSCD 北大核心 2004年第1期43-48,共6页 Chinese Journal of Biotechnology
基金 国家"8 63"计划基金项目资助 (No .2 0 0 1AA2 15 0 5 1 2 0 0 2AA2Z3 3 0 9)~~
关键词 淋巴毒素 随机突变 分子进化 点突变 组合文库 Lymphotoxin, random mutation, molecular evolution
  • 相关文献

参考文献12

  • 1[1]Nina LP, Nancy HR. Lymphotoxin. Ann Rev Immunol, 1988,6:407-438
  • 2[2]David WB, Allan D, Wolfgand J et al. Crystal structure of the soluble human 55kD TNF receptor-human TNF-beta complex: implications for TNF receptor activation. Cell, 1993, 73(7):431-445
  • 3[3]Marcus S, Sigrun H, Philip B et al. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. Eur J Immunol, 1995, 25:2183-2189
  • 4[4]Rossi D, Gaidano G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica, 2003, 88(2):212-218
  • 5[5]Eck MJ, Ultsch M, Rinderknecht E et al. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9- A resolution. J Biol Chem, 1992, 267(4):2119-2122
  • 6[6]Cynthia RG, Chong SL, Alan GP. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumor necrosis factor beta (lymphotoxin). Prot Engin, 1991, 4(7):785-791
  • 7[7]Joyce GF. Evolutionary chemistry: getting there from here. Science, 1997, 276(5319):1658-1659
  • 8[8]Brookfield JF. Making selection work. Nature, 1995, 375(6531): 449
  • 9[9]Stemmer WP. Rapid evolution of a protein in vitro by DNA shuffling. Nature, 1994, 370(6488):389-391
  • 10[10]Pedersen H, Holder S, Sutherlin DP et al. A method for directed evolution and functional cloning of enzymes. Proc Natl Acad Sci USA, 1998, 95(18):10523-10528

同被引文献40

  • 1沈毅珺,潘卫,许燕,王征,杨彤,谭靖伟,吴劲松,吴芳,曹峰,刘彦君.噬菌体展示重组人淋巴毒素突变体库及受体亲和筛选[J].生物化学与生物物理进展,2005,32(1):75-80. 被引量:7
  • 2Wallach D, Varfolomeev E E, Malinin N L, et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol,1999, 17:331~367.
  • 3Schwandner R, Wiegrnann K, Bemardo K, et al. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem, 1998, 273 (10): 5916~5922.
  • 4Qin Z, van Tits L J, Buurman W A, et al. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice. Blood, 1995, 85 (10):2779~2785.
  • 5Eck M J, Ultsch M, Rinderknecht E, et al. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J Biol Chem, 1992, 267 (4): 2119~2122.
  • 6Schuchmann M, Hess S, Buffer P, et al. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. Eur J Immunol,1995, 25 (8): 2183~2189.
  • 7Crowe P D, VanArsdale T L, Walter B N, et al. A Iymphotoxin-beta-specific receptor. Science, 1994, 264 (5159):707~710.
  • 8Medvedev A E, Espevik T, Ranges G, et al. Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects. J Biol Chem, 1996, 271 (16): 9778~9784.
  • 9Kuprash D V, Alimzhanov M B, Tumanov A V, et al. Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice. Mol Cell Biol, 2002, 22 (24): 8626~8634.
  • 10Kobayashi Y, Miyamoto D, Asada M, et al. Cloning and expression of human lymphotoxin mRNA derived from a human T cell hybridoma. J Biochem, 1986, 100 (3): 727~733.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部